Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis [Phase 4]
This document reports a Phase 4 clinical trial comparing cryotherapy to topical 5-fluorouracil for actinic keratosis, focusing on efficacy a…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses [Phase 2]
A Phase 2 trial evaluated short contact protocols to reduce pain during red-light photodynamic therapy with 10% ALA gel for actinic keratosi…
-
CLINICAL_TRIALS other · 2025-09-24Clinical Trial Update: Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a topical combination of calcipotriene and 5-fluorouracil for actinic keratosis in …
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Comparison of Nicotinamide Treatments for Actinic Keratosis [Phase 1]
A Phase 1 clinical trial comparing nicotinamide treatments for actinic keratosis has completed. The study was sponsored by the Federal Unive…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis [Phase 3]
A Phase 3 clinical trial is evaluating Veregen 10% Ointment as a topical treatment for actinic keratosis of the face and scalp, currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-07-22EMA Authorised: Zyclara (imiquimod) — Viatris Healthcare Limited
The EMA authorised Zyclara (imiquimod) for actinic keratosis, with Viatris Healthcare Limited listed as the marketing authorisation holder.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis [Phase 2]
Phase 2 study evaluating the safety and efficacy of Bimiralisib Gel in actinic keratosis has completed.
-
EMA approval · 2025-07-18EMA Authorised: Aldara (imiquimod) — Viatris Healthcare Limited
The European Medicines Agency authorised Aldara (imiquimod) for multiple indications under Viatris Healthcare Limited, including genital war…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns
A clinical trial is evaluating the efficacy and tolerability of topical tirbanibulin for actinic keratoses and is currently recruiting parti…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
A University of Palermo–sponsored clinical trial is recruiting to evaluate machine learning algorithms for interpreting oral carcinogenesis …
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis [Phase 4]
Phase 4 clinical trial evaluating whether combining 5-fluorouracil with calcipotriol is more effective than 5-fluorouracil alone for actinic…
-
CLINICAL_TRIALS withdrawal · 2025-05-07Clinical Trial Update: Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]
A Phase 2 trial evaluating immunotherapy after organ transplantation to prevent skin cancer in transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer [Phase 3]
Phase 3 trial evaluating Photodynamic Therapy with Metvix cream in organ transplant recipients with non-melanoma skin cancers completed; res…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: The Influence of an E-learning Program on Recognition of Actinic Keratosis
This clinical trial update reports on an active-not-recruiting study sponsored by Maastricht University Medical Center investigating an e-le…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: OCT and Invasion in Cutaneous Skin Lesions
A completed clinical trial from Maastricht University Medical Center evaluating OCT imaging and invasion in cutaneous skin lesions. The stud…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: High- and Low-risk Actinic Keratosis Referrals to Secondary Care
Maastricht University Medical Center reports an active, non-recruiting clinical trial evaluating referral patterns for high- and low-risk ac…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Patient Decision Aid for the Treatment of Actinic Keratosis [NA]
This document provides an update on a clinical trial involving a patient decision aid for the treatment of actinic keratosis, with the study…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia [NA]
A clinical trial is evaluating whether fractionated laser resurfacing can protect geriatric skin from actinic neoplasia, including actinic k…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp [Phase 4]
Phase 4 trial comparing ingenol mebutate gel 0.015% with diclofenac sodium gel 3% for actinic keratoses on the face or scalp, evaluating eff…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of different concentrations of an ingenol derivative topical therapy for actinic kera…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Biological Effects of LEO 43204 in Actinic Keratosis [Phase 1]
This Phase 1 trial evaluated the biological effects of the topical agent LEO 43204 in actinic keratosis and has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel [Phase 1]
Phase 1 study evaluating the sensitizing potential of LEO 43204 Gel in actinic keratosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% [Phase 1]
This Phase 1 trial of Ingenol Mebutate Gel 0.05% for actinic keratosis reports histological confirmation of clinical clearance after treatme…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm [Phase 1, Phase 2]
A completed Phase 1/Phase 2 safety and dose-finding trial evaluating new vehicle formulations containing Ingenol Mebutate for actinic kerato…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology [Phase 1]
Phase 1 trial update showing biological effects of PEP005 Gel in actinic keratosis as assessed by histology; study completed.